Kinder Morgan, Inc. (NYSE: KMI) today announced it has completed its
acquisition of the outstanding equity securities of Kinder Morgan Energy
Partners, L.P. (NYSE: KMP), Kinder Morgan Management, LLC (NYSE: KMR)
and El Paso Pipeline Partners, L.P. (NYSE: EPB). The approximately $76
billion transaction was initially announced Aug.
RIO DE JANEIRO, BR--(Marketwired - November 14, 2014) - Brazil Fast Food Corp.
Sign-up for Merrimack Pharmaceuticals Announces Oral Presentation of Additional Analyses of MM-398 Phase 3 NAPOLI-1 Study at the American Society of Clinical Oncology (ASCO) 2015 Gastrointestinal Cancers Symposium investment picks
By Chelsey Dulaney
Embattled for-profit college operator Corinthian Colleges Inc. agreed to sell the bulk of its campuses to a newly formed unit of student loan guarantor ECMC Group Inc. for $24 million as it winds down its operations.
Dunkin' Donuts readies for National Cookie Day with special Twitter sweepstakes to celebrate holiday and brand's cookie-flavored coffee and lattes For Cyber Monday, Dunkin' Donuts Packaged Coffee deal and Dunkin' Donuts Cards can keep friends, family and co-workers running on Dunkin' throughout the holidays and into 2015
By Erik Holm
Looks like investors are hungry to scoop up shares of newly-public Habit Restaurants Inc.
The burger chain priced its initial public offering at $18 Wednesday night, above expectations, and shares are now soaring in its trading debut.
By Jennifer Booton, MarketWatch How Shutterfly plans to make money from this 'Shark Tank' winner
Shutterfly Inc. agreed to buy "Shark Tank" success GrooveBook for $14.5 million on Tuesday, hoping to leverage its 1 million app downloads to boost mobile revenues as people continue to print fewer pictures.
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and
development-focused biotechnology company dedicated to creating small
molecule drugs primarily in the infectious disease field, today
announced that the European Committee for Medicinal Products for Human
Use (CHMP) of the European Medicines Agency (EMA) has granted positive
opinions for AbbVie’s investigational, all-oral, interferon-free
treatment of VIEKIRAX™ (a combination of ombitasvir, paritaprevir
(ABT-450) and ritonavir) plus EXVIERA™ (dasabuvir), with or without
ribavirin (RBV), for patients with genotype 1 (GT1) chronic hepatitis C
virus (HCV) infection, and VIEKIRAX™ only, with RBV, for patients with
genotype 4 (GT4) HCV infection.
Sign-up for Enanta Announces CHMP Grants Positive Opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe investment picks
EVERTEC, Inc. (NYSE: EVTC) (“EVERTEC” or the “Company”) today announced
the appointment of Morgan "Mac" Schuessler as President and Chief
Executive Officer, and Member of the Board of Directors, effective
January 1, 2015.
The Charles Schwab Corporation (Schwab) today announced additional
details about the company’s new automated investment advisory service, Schwab
Intelligent Portfolios™ , which it plans to make available
to retail investors in the first quarter of 2015, with a white label
version for Registered Investment Advisors available shortly thereafter.
Nuveen Investments, a leading global provider of investment services to
institutions as well as individual investors, today announced that the
Board of Trustees of Nuveen Global High Income Fund has approved a
tender offer for the fund to purchase up to 25 percent of its
outstanding common shares for cash at a price per share equal to 98
percent of the net asset value per share as of the purchase date,
contingent upon the successful completion of the previously
announced merger and combination of Nuveen Global Income
Opportunities Fund (NYSE: JGG) and Nuveen Diversified Currency
Opportunities Fund (NYSE: JGT) into the fund.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.